Work

Assessment of alemtuzumab third dose for resumed MS activity; two North-East England centres experience

Year: 2024
Type: conference-paper
Study design: Observational Study
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4404183225
FWCI:
Cites:
Cited by:
Related to: 10